Andrzej Andraczke

Insider Reports History

Entity
Individual
Location
C/O Cns Pharmaceuticals, Inc., 2100 West Loop South Ste 900, Houston, TX
Signature
/s/ Christopher Downs, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrzej Andraczke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CNS Pharmaceuticals, Inc. Director Option to purchase common stock 45.4K Sep 21, 2023 Direct

Insider Reports Filed by Andrzej Andraczke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNSP CNS Pharmaceuticals, Inc. Sep 21, 2023 1 $0 4/A Oct 12, 2023 Director
CNSP CNS Pharmaceuticals, Inc. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director